Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
In a statement sent to Reuters, Novartis did not confirm the value of the deal but said Siemens Healthineers would remain a partner in the Novartis radioligand therapy business, adding that it expects the transaction to close in the fourth quarter.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Fonte: YahooFinanceCA - 🏆 47. / 63 Consulte Mais informação »
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Fonte: YahooFinanceCA - 🏆 47. / 63 Consulte Mais informação »
A German diaspora in North Carolina is booming thanks to a multibillion-dollar investment from Germany, but a potential Trump Presidency is causing anxietyThousands of Germans have flocked to North Carolina in recent years, aided by investments from Siemens and Daimler.
Fonte: YahooFinanceCA - 🏆 47. / 63 Consulte Mais informação »